XOMA Competitors & Alternatives

Compare XOMA Royalty Corporation with similar stocks in the same industry

Biotechnology

XOMA

Main Stock
$40.17
-9.16%
Tradestie Score
46
Market Cap
$474.20M
P/E Ratio
28.2
Revenue Growth
-22.6%
Analyst Upside
-2.9%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other Biotech Royalties
Competitive Moat: None
Major Customers 3
biotech and pharma partners Novartis various development-stage companies
Critical Suppliers 0
Internal vertical integration & multi-sourced components.
Direct Ecosystem Rivals 1

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
KOD Kodiak Sciences Inc Common Stock
$103.51
-6.91%
$832.47M - 39 Compare
URGN UroGen Pharma Ltd. Ordinary Shares
$28.01
+6.99%
$824.20M - 61 Compare
IVA Inventiva S.A. American Depository Shares
$3.34
-9.38%
$821.84M - 40 Compare
MBX MBX Biosciences, Inc. Common Stock
$53.69
-4.02%
$800.41M - 45 Compare
IOVA Iovance Biotherapeutics, Inc. Common Stock
$7.63
-1.71%
$799.70M - 68 Compare
KURA Kura Oncology, Inc.
$7.30
-6.05%
$798.53M - 63 Compare
VIR Vir Biotechnology, Inc. Common Stock
$9.76
-2.01%
$791.82M - 35 Compare
OLMA Olema Pharmaceuticals, Inc. Common Stock
$7.15
-5.42%
$757.72M - 33 Compare
AVBP ArriVent BioPharma, Inc. Common Stock
$11.86
-8.84%
$748.90M - 45 Compare
TBPH Theravance Biopharma, Inc.
$17.03
$726.21M 16.4 51 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry